{"title":"mirna在人类疾病中对自噬的调控。","authors":"Sounak Ghosh Roy","doi":"10.1007/s13237-021-00378-9","DOIUrl":null,"url":null,"abstract":"<p><p>Autophagy is a homeostatic process designed to eliminate dysfunctional and aging organelles and misfolded proteins through a well-concerted pathway, starting with forming a double-membrane vesicle and culminating in the lysosomal degradation of the cargo enclosed inside the mature vesicle. As a vital sentry of cellular health, autophagy is regulated in every human disease condition and is an essential target for non-coding RNAs like microRNAs (miRNAs). miRNAs are short oligonucleotides that specifically bind to the 3'-untranslated region (UTR) of target mRNAs, thus leading to mRNA silencing, degradation, or translation blockage. This review summarizes the recent findings regarding the regulation of autophagy and autophagy-related genes by different miRNAs in various pathological conditions, including cancer, kidney and liver disorders, neurodegeneration, cardiovascular disorders, infectious diseases, aging-related conditions, and inflammation-related diseases. As miRNAs are being identified as prime regulators of autophagy in human disease, pharmacological molecules and traditional medicines targeting these miRNAs are also being tested in disease models, thus initiating a new series of therapeutic interventions targeting autophagy.</p>","PeriodicalId":53176,"journal":{"name":"Nucleus (India)","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520464/pdf/","citationCount":"14","resultStr":"{\"title\":\"Regulation of autophagy by miRNAs in human diseases.\",\"authors\":\"Sounak Ghosh Roy\",\"doi\":\"10.1007/s13237-021-00378-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Autophagy is a homeostatic process designed to eliminate dysfunctional and aging organelles and misfolded proteins through a well-concerted pathway, starting with forming a double-membrane vesicle and culminating in the lysosomal degradation of the cargo enclosed inside the mature vesicle. As a vital sentry of cellular health, autophagy is regulated in every human disease condition and is an essential target for non-coding RNAs like microRNAs (miRNAs). miRNAs are short oligonucleotides that specifically bind to the 3'-untranslated region (UTR) of target mRNAs, thus leading to mRNA silencing, degradation, or translation blockage. This review summarizes the recent findings regarding the regulation of autophagy and autophagy-related genes by different miRNAs in various pathological conditions, including cancer, kidney and liver disorders, neurodegeneration, cardiovascular disorders, infectious diseases, aging-related conditions, and inflammation-related diseases. As miRNAs are being identified as prime regulators of autophagy in human disease, pharmacological molecules and traditional medicines targeting these miRNAs are also being tested in disease models, thus initiating a new series of therapeutic interventions targeting autophagy.</p>\",\"PeriodicalId\":53176,\"journal\":{\"name\":\"Nucleus (India)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520464/pdf/\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nucleus (India)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13237-021-00378-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/10/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nucleus (India)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13237-021-00378-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/16 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
Regulation of autophagy by miRNAs in human diseases.
Autophagy is a homeostatic process designed to eliminate dysfunctional and aging organelles and misfolded proteins through a well-concerted pathway, starting with forming a double-membrane vesicle and culminating in the lysosomal degradation of the cargo enclosed inside the mature vesicle. As a vital sentry of cellular health, autophagy is regulated in every human disease condition and is an essential target for non-coding RNAs like microRNAs (miRNAs). miRNAs are short oligonucleotides that specifically bind to the 3'-untranslated region (UTR) of target mRNAs, thus leading to mRNA silencing, degradation, or translation blockage. This review summarizes the recent findings regarding the regulation of autophagy and autophagy-related genes by different miRNAs in various pathological conditions, including cancer, kidney and liver disorders, neurodegeneration, cardiovascular disorders, infectious diseases, aging-related conditions, and inflammation-related diseases. As miRNAs are being identified as prime regulators of autophagy in human disease, pharmacological molecules and traditional medicines targeting these miRNAs are also being tested in disease models, thus initiating a new series of therapeutic interventions targeting autophagy.
Nucleus (India)Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
3.90
自引率
0.00%
发文量
26
期刊介绍:
The journal publishes original, peer-reviewed articles on new and significant advances in all aspects of cell and chromosome research. Timely and substantial articles in the areas of cell biology, genetic toxicology, chromosome evolution, cytogenetics; molecular-, population- and evolutionary genetics; epigenetics; developmental and stress biology; transcriptomics, structural and functional genomics, proteomics, metabolomics, integrated omics and use of tools of bioinformatics in the areas stated herein. Studies demonstrating the use of modern approaches such as genome editing to address technological problems and/or biological questions pertaining to the research areas mentioned above are encouraged. However, the studies should be conducted with appropriate scientific rigor in the design, conduct, validity, and interpretation of results to ensure reliability and reproducibility of the data presented. The papers must be written concisely and be of interest to a broad audience.
The journal also publishes comprehensive reviews on current developments and future trends in cell and chromosome research. Such articles should be authoritative, covering all the aspects of a chosen topic, and serve as a resource for students, researchers, and multidisciplinary audience. Authors are welcome to contact the Editor-in-Chief to discuss their topic of interest while preparing a prospective review article.
Thematic special issues on cutting edge research in the development of the above stated areas are periodically published by the journal. Articles for such issues are commissioned by the respective topic editor/s.